Hsp90 Inhibitor STA9090 induced VPS35 related extracellular vesicle release and metastasis in hepatocellular carcinoma

Heat shock protein 90 (Hsp90) has been an important therapeutic target for cancer therapy for decades. Unexpectedly, the monotherapy of N-terminal Hsp90 inhibitor STA9090 related clinical trials halted in phase III, and metastases were reported in animal models with the treatment of N-terminal Hsp90...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Wenchong, Zhang, Jinxin, Liu, Lixia, Liang, Manfeng, Li, Jieyou, Deng, Zihao, Zheng, Zhenming, Deng, Yaotang, Liu, Chenyang, Li, Yan, Xie, Guantai, Zhang, Jiajie, Zou, Fei, Chen, Xuemei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493061/
https://www.ncbi.nlm.nih.gov/pubmed/36137350
http://dx.doi.org/10.1016/j.tranon.2022.101502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493061/
https://www.ncbi.nlm.nih.gov/pubmed/36137350
http://dx.doi.org/10.1016/j.tranon.2022.101502

Ejemplares similares